The CTLA4 inhibitor – now given the brand name Imjudo – is only the second drug in the class to be ... for the application to six months. In the HIMALAYA trial, patients treated with the ...
This information is disclosed as required by Regulation EU596/2014 ("MAR"), article 19 and section 5-12 of the Norwegian Securities Trading Act. To subscribe to Press releases from this issuer, visit ...
Sandoz, CIBA-Geigy, Roche and the Basel hub of the pharmaceutical industry all have their roots in this boom. It wasn’t just Swiss companies that had their roots in the dye trade. Bayer was ...
The drug companies, McKesson and AmerisourceBergen, will pay $192 million and $74 million respectively if the verdict survives a likely appeal. The verdict means the jury of three men and three women ...
From there, we embarked on a slow journey up into the Himalaya. Soon the smooth tarmac roads disappeared, and we needed a 4x4 to navigate the rough tracks that wound their way into the mountains.
The pharma giant has hired Goldman Sachs to gauge initial interest from potential buyers, which include private equity firms and other pharmaceutical companies, the sources said, requesting ...
Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and its intermediates. The Company is engaged in the ...